BioElectronics (BIEL) Regains Momentum: What Now?

After having recorded significant gains last month, BioElectronics Corporate (OTC: BIEL) seems to have come back into the radars of investors once again.

On Friday, the stock gained considerable momentum and managed to clock gains of as big as 19% as investors flocked to the BioElectronics stock in a big way. Last month, the stock had recorded considerable gains as well and like this time, there was no news about the company at that time that could have brought about those gains.

In a situation in which there is not much for investors to look into, it might be a sound move to actually take a look at BioElectronics’ financial results. The company released its fourth-quarter results back in January, BioElectronics generated revenues of $519,000, which reflected year-on-year growth of as high as 233%. Hence, the optimism about the stock may not be entirely misplaced. It might be a good move to keep an eye on any news regarding BioElectronics.

Michael Rowels

Weekend Contributor. Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.

Want Hot Stocks?    Yes. I Love Them No thanks